• Something wrong with this record ?

Added Value in Low-Risk Pregnancies of Longitudinal Changes in Uterine Doppler and Circulating Angiogenic Factors during the Third Trimester in Predicting Term Preeclampsia

L. Roubalova, V. Kroutilova, MF. Lopez-G Tinajero, J. Martinez-Egea, C. Pumarola, F. Figueras, M. Lubusky

. 2025 ; 52 (3) : 233-242. [pub] 20241104

Language English

Document type Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial

INTRODUCTION: The objective of this study was to assess the relationship between longitudinal changes in the uterine Doppler velocimetry and the maternal profile of angiogenic factors in the third trimester and to assess their ability to predict term preeclampsia (PE). METHODS: A cohort of low-risk pregnant women was scheduled for a uterine Doppler evaluation and measurement of the circulating levels of angiogenic factors at ∼30 and ∼36 weeks. The performance of both parameters and their change over time in predicting term PE was evaluated. RESULTS: A total of 1,191 women were analyzed, of which 28 (2.4%) women developed term PE. At ∼30 weeks, a model including the sFlt-1/PlGF (fms-like tyrosine kinase-1/placental growth factor) ratio and the uterine Doppler explained 16.2% of the uncertainty of developing term PE, while at ∼36 weeks, the same variables explained 25.2% [p < 0.001]. The longitudinal changes of both predictors had an R2 of 26.8%, which was not different from that of the ∼36 weeks evaluation [p = 0.45]. The area under the curve (AUC) of the ∼36 weeks ratio was significantly higher than at ∼30 weeks (0.86 [0.77-0.94] vs. 0.81 [0.73-0.9]; p = 0.043). The AUC of the longitudinal change of the ratio (0.85 [0.77-0.94]) did not differ from that of at ∼36 weeks (p = 0.82). At ∼36 weeks, for a 10% of false positives, the ratio had a detection rate of 71.4%. CONCLUSION: A cross-sectional measurement of the sFlt-1/PlGF ratio outperforms uterine Doppler in predicting term PE. The combination of both markers does not improve such prediction, nor the evaluation of the longitudinal changes between weeks.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25016435
003      
CZ-PrNML
005      
20250731092912.0
007      
ta
008      
250708s2025 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000541731 $2 doi
035    __
$a (PubMed)39496230
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a x
100    1_
$a Roubalova, Lucie $u Department of Obstetrics and Gynecology, Palacky University Olomouc, Olomouc, Czechia
245    10
$a Added Value in Low-Risk Pregnancies of Longitudinal Changes in Uterine Doppler and Circulating Angiogenic Factors during the Third Trimester in Predicting Term Preeclampsia / $c L. Roubalova, V. Kroutilova, MF. Lopez-G Tinajero, J. Martinez-Egea, C. Pumarola, F. Figueras, M. Lubusky
520    9_
$a INTRODUCTION: The objective of this study was to assess the relationship between longitudinal changes in the uterine Doppler velocimetry and the maternal profile of angiogenic factors in the third trimester and to assess their ability to predict term preeclampsia (PE). METHODS: A cohort of low-risk pregnant women was scheduled for a uterine Doppler evaluation and measurement of the circulating levels of angiogenic factors at ∼30 and ∼36 weeks. The performance of both parameters and their change over time in predicting term PE was evaluated. RESULTS: A total of 1,191 women were analyzed, of which 28 (2.4%) women developed term PE. At ∼30 weeks, a model including the sFlt-1/PlGF (fms-like tyrosine kinase-1/placental growth factor) ratio and the uterine Doppler explained 16.2% of the uncertainty of developing term PE, while at ∼36 weeks, the same variables explained 25.2% [p < 0.001]. The longitudinal changes of both predictors had an R2 of 26.8%, which was not different from that of the ∼36 weeks evaluation [p = 0.45]. The area under the curve (AUC) of the ∼36 weeks ratio was significantly higher than at ∼30 weeks (0.86 [0.77-0.94] vs. 0.81 [0.73-0.9]; p = 0.043). The AUC of the longitudinal change of the ratio (0.85 [0.77-0.94]) did not differ from that of at ∼36 weeks (p = 0.82). At ∼36 weeks, for a 10% of false positives, the ratio had a detection rate of 71.4%. CONCLUSION: A cross-sectional measurement of the sFlt-1/PlGF ratio outperforms uterine Doppler in predicting term PE. The combination of both markers does not improve such prediction, nor the evaluation of the longitudinal changes between weeks.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a těhotenství $7 D011247
650    _2
$a dospělí $7 D000328
650    _2
$a prediktivní hodnota testů $7 D011237
650    12
$a třetí trimestr těhotenství $x krev $x fyziologie $7 D011263
650    _2
$a ultrasonografie dopplerovská $x metody $x statistika a číselné údaje $7 D018608
650    12
$a ultrasonografie prenatální $x metody $x statistika a číselné údaje $7 D016216
650    12
$a preeklampsie $x krev $x diagnostické zobrazování $7 D011225
650    _2
$a placentární oběh $x fyziologie $7 D021041
650    _2
$a rychlost toku krve $x fyziologie $7 D001783
650    12
$a reologie $x metody $x statistika a číselné údaje $7 D012212
650    _2
$a plocha pod křivkou $7 D019540
650    12
$a receptor 1 pro vaskulární endoteliální růstový faktor $x krev $7 D040281
650    12
$a placentární růstový faktor $x krev $7 D000072483
650    _2
$a reprodukovatelnost výsledků $7 D015203
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Kroutilova, Vladimira $u Department of Obstetrics and Gynecology, Palacky University Olomouc, Olomouc, Czechia
700    1_
$a Lopez-G Tinajero, Maria Fernanda $u BCNatal (Hospital Clinic and Hospital Sant Joan de Deu), Universitat de Barcelona, Barcelona, Spain
700    1_
$a Martinez-Egea, Judit $u BCNatal (Hospital Clinic and Hospital Sant Joan de Deu), Universitat de Barcelona, Barcelona, Spain
700    1_
$a Pumarola, Claudia $u BCNatal (Hospital Clinic and Hospital Sant Joan de Deu), Universitat de Barcelona, Barcelona, Spain
700    1_
$a Figueras, Francesc $u BCNatal (Hospital Clinic and Hospital Sant Joan de Deu), Universitat de Barcelona, Barcelona, Spain
700    1_
$a Lubusky, Marek $u Department of Obstetrics and Gynecology, Palacky University Olomouc, Olomouc, Czechia
773    0_
$w MED00001797 $t Fetal diagnosis and therapy $x 1421-9964 $g Roč. 52, č. 3 (2025), s. 233-242
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39496230 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731092906 $b ABA008
999    __
$a ok $b bmc $g 2366939 $s 1253560
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 52 $c 3 $d 233-242 $e 20241104 $i 1421-9964 $m Fetal diagnosis and therapy $n Fetal Diagn Ther $x MED00001797
LZP    __
$a Pubmed-20250708

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...